HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 4.9 CAD -0.2% Market Closed
Market Cap: 153.3m CAD

HLS Therapeutics Inc
Change in Deffered Taxes

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

HLS Therapeutics Inc
Change in Deffered Taxes Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Deffered Taxes CAGR 3Y CAGR 5Y CAGR 10Y
HLS Therapeutics Inc
TSX:HLS
Change in Deffered Taxes
-$481k
CAGR 3-Years
N/A
CAGR 5-Years
32%
CAGR 10-Years
N/A
No Stocks Found

HLS Therapeutics Inc
Glance View

Market Cap
153.2m CAD
Industry
Health Care

HLS Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Etobicoke, Ontario and currently employs 92 full-time employees. The firm is focused on developing clinically differentiated pharmaceutical products in the specialty central nervous system (CNS) and cardiovascular (CV) markets. Its products include Vascepa, Trinomia, Clozaril, CSAN Pronto, PERSERIS and MyCare Psychiatry/MyCare Insite. Its lead product, Clozaril, is an atypical antipsychotic indicated in the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. Vascepa capsules reduce the risk of cardiovascular events, such as cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularization, or hospitalization for unstable angina in statin-treated patients with elevated triglycerides.

HLS Intrinsic Value
11.79 CAD
Undervaluation 58%
Intrinsic Value
Price

See Also

What is HLS Therapeutics Inc's Change in Deffered Taxes?
Change in Deffered Taxes
-481k USD

Based on the financial report for Sep 30, 2025, HLS Therapeutics Inc's Change in Deffered Taxes amounts to -481k USD.

What is HLS Therapeutics Inc's Change in Deffered Taxes growth rate?
Change in Deffered Taxes CAGR 5Y
32%

Back to Top